Twist Bioscience

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries.^[2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.

Twist Bioscience

Company type	Public
Traded as	Nasdaq: TWST Russell 2000 component
Industry	synthetic biology
Founded	2013; 12 years ago (2013)
Founders	Emily Leproust Bill Banyai Bill Peck
Headquarters	South San Francisco, California
Products	Genes and gene fragments, NGS products
Revenue	$54.2 million(2019)[1]
Number of employees	400
Website	twistbioscience.com

The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.^[3]

In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.^[4]